Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care cash
Cash and short-term investments held at the end of each period.
Tandem Diabetes Care's cash was $456.00M at Jun 30, 2026. For fiscal 2025 it was $292.67M, down 33.2% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $623.81M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $292.67M | -33.2% |
| FY2024 | Dec 31, 2024 | $438.33M | -6.3% |
| FY2023 | Dec 31, 2023 | $467.91M | -24.2% |
| FY2022 | Dec 31, 2022 | $616.90M | -1.1% |
| FY2021 | Dec 31, 2021 | $623.81M | +28.6% |
| FY2020 | Dec 31, 2020 | $484.94M | +174.8% |
| FY2019 | Dec 31, 2019 | $176.50M | +36.8% |
| FY2018 | Dec 31, 2018 | $129.00M | +433.5% |
| FY2017 | Dec 31, 2017 | $24.18M | -54.8% |
| FY2016 | Dec 31, 2016 | $53.50M | -24.8% |
| FY2015 | Dec 31, 2015 | $71.11M | +5.7% |
| FY2014 | Dec 31, 2014 | $67.28M | -48.0% |
| FY2013 | Dec 31, 2013 | $129.48M | +654.4% |
| FY2012 | Dec 31, 2012 | $17.16M | +98.3% |
| FY2011 | Dec 31, 2011 | $8.66M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $456.00M | +44.6% |
| Q1 FY2026 | Mar 31, 2026 | $570.26M | +54.7% |
| Q4 FY2025 | Dec 31, 2025 | $292.67M | -33.2% |
| Q3 FY2025 | Sep 30, 2025 | $319.11M | -32.6% |
| Q2 FY2025 | Jun 30, 2025 | $315.36M | -30.3% |
| Q1 FY2025 | Mar 31, 2025 | $368.63M | -21.2% |
| Q4 FY2024 | Dec 31, 2024 | $438.33M | -6.3% |
| Q3 FY2024 | Sep 30, 2024 | $473.31M | -5.0% |
| Q2 FY2024 | Jun 30, 2024 | $452.42M | -10.8% |
| Q1 FY2024 | Mar 31, 2024 | $467.81M | -10.0% |
| Q4 FY2023 | Dec 31, 2023 | $467.91M | -24.2% |
| Q3 FY2023 | Sep 30, 2023 | $498.16M | -18.2% |
| Q2 FY2023 | Jun 30, 2023 | $507.25M | -20.2% |
| Q1 FY2023 | Mar 31, 2023 | $519.59M | -18.2% |
| Q4 FY2022 | Dec 31, 2022 | $616.90M | -1.1% |
| Q3 FY2022 | Sep 30, 2022 | $608.73M | +2.3% |
| Q2 FY2022 | Jun 30, 2022 | $635.33M | +16.5% |
| Q1 FY2022 | Mar 31, 2022 | $635.39M | +23.8% |
| Q4 FY2021 | Dec 31, 2021 | $623.81M | +28.6% |
| Q3 FY2021 | Sep 30, 2021 | $594.99M | +28.1% |
| Q2 FY2021 | Jun 30, 2021 | $545.30M | +27.9% |
| Q1 FY2021 | Mar 31, 2021 | $513.44M | +220.5% |
| Q4 FY2020 | Dec 31, 2020 | $484.94M | +174.8% |
| Q3 FY2020 | Sep 30, 2020 | $464.50M | +196.0% |
| Q2 FY2020 | Jun 30, 2020 | $426.30M | +224.4% |
| Q1 FY2020 | Mar 31, 2020 | $160.20M | +27.5% |
| Q4 FY2019 | Dec 31, 2019 | $176.50M | +36.8% |
| Q3 FY2019 | Sep 30, 2019 | $156.90M | +38.1% |
| Q2 FY2019 | Jun 30, 2019 | $131.40M | +51.9% |
| Q1 FY2019 | Mar 31, 2019 | $125.60M | +74.7% |
| Q4 FY2018 | Dec 31, 2018 | $129.00M | +433.5% |
| Q3 FY2018 | Sep 30, 2018 | $113.60M | +806.0% |
| Q2 FY2018 | Jun 30, 2018 | $86.51M | +128.9% |
| Q1 FY2018 | Mar 31, 2018 | $71.88M | +38.2% |
| Q4 FY2017 | Dec 31, 2017 | $24.18M | -54.8% |
| Q3 FY2017 | Sep 30, 2017 | $12.54M | -63.2% |
| Q2 FY2017 | Jun 30, 2017 | $37.79M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $34.08M | – |
See a number that looks wrong?